Full Press Release Details
NORTH CHICAGO, Ill.,Nov. 13, 2025/PRNewswire/ -- AbbVie (NYSE:ABBV) today announced the 20 recipients of its second annual AbbVie Migraine Career Catalyst Award™ contest, an initiative that helps people living with migraine pursue their career and professional development goals. Each winner received $2,500 in financial support to invest in opportunities that advance their aspirations, from continued education and training to creating healthier, more supportive work environments.
Migraine affects one in six people and is present in nearly every workplace. Still, despite its widespread impact and significant costs, awareness and understanding remain limited. Amid these challenges, many people living with migraine continue to redefine what is possible, showing remarkable resilience and advocacy in both their personal and professional lives.
The contest drew entries from across the United States, with winners representing a broad mix of professions and life stages. Despite the challenges that migraine often presents, each recipient shared a powerful story of resilience, ambition, and commitment to advancing their professional goals. Among the 20 awardees, several shared reflections on what the recognition means to them and how it will help shape their professional paths:
Many people with migraine continue to face stigma, bias and insufficient support in their professional lives.2The AbbVie Migraine Career Catalyst Award contest was created to help close this gap, providing recognition, resources, and visibility for individuals whose careers have been disrupted by migraine. By supporting their goals, AbbVie is helping to foster greater understanding of the realities of living and working with migraine.
"AbbVie is helping shift how workplaces and society understand migraine, while empowering individuals to thrive and pursue their goals," said Jag Dosanjh, senior vice president, AbbVie, and president, neuroscience and eye care. "We recognize that migraine doesn't just interrupt workdays, it can alter career trajectories. We're proud to be the only company to offer three treatment options that address the spectrum of migraine and we are continuing to research and drive innovation to uncover new therapies that can help people living with this debilitating disease."
For the complete list of 2025 winners, visitwww.migrainecareercatalyst.com.